How has been the historical performance of Samrat Pharma?

Nov 17 2025 10:54 PM IST
share
Share Via
Samrat Pharma's historical performance shows fluctuating financial metrics, with net sales rising from INR 137.45 crore in March 2020 to a peak of INR 310.65 crore in March 2023, followed by a decline and slight recovery. Key indicators like operating profit and profit after tax also experienced significant volatility during this period.
Answer:
The historical performance of Samrat Pharma shows a fluctuating trend in key financial metrics over the years.

Breakdown:
Samrat Pharma's net sales increased from INR 137.45 crore in March 2020 to INR 285.86 crore in March 2025, with a peak of INR 310.65 crore in March 2023. However, there was a decline in net sales from March 2023 to March 2024, followed by a slight recovery in March 2025. The total operating income mirrored this trend, reaching INR 310.65 crore in March 2023 before dropping to INR 281.58 crore in March 2024 and rebounding to INR 285.86 crore in March 2025. The operating profit (PBDIT) saw significant fluctuations, peaking at INR 24.89 crore in March 2022, then dropping to INR 2.47 crore in March 2024, and recovering to INR 10.24 crore in March 2025. Profit after tax also exhibited volatility, with a high of INR 16.63 crore in March 2023, declining to INR 2.16 crore in March 2024, and then increasing to INR 7.11 crore in March 2025. The company's total assets grew from INR 58.35 crore in March 2020 to INR 121.49 crore in March 2025, while total liabilities remained relatively stable, peaking at INR 121.74 crore in March 2024. Cash flow from operating activities was negative in March 2025 at INR -10 crore, contrasting with a positive cash flow of INR 9 crore in March 2024. Overall, Samrat Pharma's financial performance reflects a mix of growth and challenges over the years.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News